Literature DB >> 8832062

Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells.

M E Cavet1, M West, N L Simmons.   

Abstract

1. Human intestinal epithelial Caco-2 cells have been used to investigate the transepithelial permeation of the cardiac glycoside, digoxin. 2. Transepithelial basal to apical [3H]-digoxin flux exceeds apical to basal flux, a net secretion of [3H]-digoxin being observed. At 200 microM digoxin, net secretory flux (Jnet) was 10.8 +/- 0.6 nmol cm-2 h-1. Maximal secretory flux (Jmax) of vinblastine was 1.3 +/- 0.1 nmol cm-2 h-1. Cellular uptake of digoxin was different across apical and basal cell boundaries. It was greatest across the basal surface at 1 microM, whereas at 200 microM, apical uptake exceeded basal uptake. 3. Net secretion of [3H]-digoxin was subject to inhibition by digitoxin and bufalin but was not inhibited by ouabain, convallatoxin, and strophanthidin (all 100 microM). Inhibition was due to both a decrease in Jb-a and an increase in Ja-b. Uptake of [3H]-digoxin at the apical surface was increased by digitoxin and bufalin. All cardiac glycosides decreased [3H]-digoxin uptake at the basal cell surface (except for 100 microM digitoxin). 4. The competitive P-glycoprotein inhibitors, verapamil (100 microM), nifedipine (50 microM) and vinblastine (50 microM) all abolished net secretion of [3H]-digoxin due to both a decrease in Jb-a and an increase in Ja-b. Cellular accumulation of [3H]-digoxin was also increased across both the apical and basal cell surfaces. I-Chloro-2,4,-dinitrobenzene (10 microM), a substrate for glutathione-S-transferase and subsequent ATP-dependent glutathione-S-conjugate secretion, failed to inhibit net secretion of [3H]-digoxin. The increase in absorptive permeability Pa-b (= Ja-b/Ca) and cellular [3H]-digoxin uptake upon P-glycoprotein inhibition, showed that the intestinal epithelium was rendered effectively impermeable by ATP-dependent extrusion at the apical surface. 5. A model for [3H]-digoxin secretion by the intestinal epithelium is likely to involve both diffusional uptake and Na(+)-K+ pump-mediated endocytosis, followed by active extrusion at the apical membrane.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8832062      PMCID: PMC1909679          DOI: 10.1111/j.1476-5381.1996.tb15550.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

Review 1.  Pharmacology of drugs that alter multidrug resistance in cancer.

Authors:  J M Ford; W N Hait
Journal:  Pharmacol Rev       Date:  1990-09       Impact factor: 25.468

2.  Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes.

Authors:  K Inui; M Yamamoto; H Saito
Journal:  J Pharmacol Exp Ther       Date:  1992-04       Impact factor: 4.030

3.  Cyclosporin and quinidine inhibition of renal digoxin excretion: evidence for luminal secretion of digoxin.

Authors:  I A De Lannoy; G Koren; J Klein; J Charuk; M Silverman
Journal:  Am J Physiol       Date:  1992-10

4.  Transport of digoxin by human P-glycoprotein expressed in a porcine kidney epithelial cell line (LLC-PK1).

Authors:  Y Tanigawara; N Okamura; M Hirai; M Yasuhara; K Ueda; N Kioka; T Komano; R Hori
Journal:  J Pharmacol Exp Ther       Date:  1992-11       Impact factor: 4.030

5.  Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H(+)-coupled carriers at both apical and basal membranes.

Authors:  D T Thwaites; C D Brown; B H Hirst; N L Simmons
Journal:  J Biol Chem       Date:  1993-04-15       Impact factor: 5.157

6.  Glutathione-conjugate transport by human colon adenocarcinoma cells (Caco-2 cells).

Authors:  R P Oude Elferink; C T Bakker; P L Jansen
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

7.  Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells.

Authors:  P S Burton; R A Conradi; A R Hilgers; N F Ho
Journal:  Biochem Biophys Res Commun       Date:  1993-02-15       Impact factor: 3.575

8.  Effect of cyclosporine on colchicine secretion by the kidney multidrug transporter studied in vivo.

Authors:  K V Speeg; A L Maldonado; J Liaci; D Muirhead
Journal:  J Pharmacol Exp Ther       Date:  1992-04       Impact factor: 4.030

9.  Biochemical characterization of resistance to mitoxantrone and adriamycin in Caco-2 human colon adenocarcinoma cells: a possible role for glutathione S-transferases.

Authors:  W H Peters; H M Roelofs
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

10.  H(+)-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics.

Authors:  D T Thwaites; C D Brown; B H Hirst; N L Simmons
Journal:  Biochim Biophys Acta       Date:  1993-09-19
View more
  22 in total

Review 1.  Drug, meal and formulation interactions influencing drug absorption after oral administration. Clinical implications.

Authors:  D Fleisher; C Li; Y Zhou; L H Pao; A Karim
Journal:  Clin Pharmacokinet       Date:  1999-03       Impact factor: 6.447

2.  Transepithelial transport of the fluoroquinolone ciprofloxacin by human airway epithelial Calu-3 cells.

Authors:  M E Cavet; M West; N L Simmons
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

Review 3.  Drug exsorption from blood into the gastrointestinal tract.

Authors:  K Arimori; M Nakano
Journal:  Pharm Res       Date:  1998-03       Impact factor: 4.200

Review 4.  Drug interactions with patient-controlled analgesia.

Authors:  Jorn Lotsch; Carsten Skarke; Irmgard Tegeder; Gerd Geisslinger
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

5.  Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure.

Authors:  M D Perloff; L L von Moltke; E Störmer; R I Shader; D J Greenblatt
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

6.  Characterization and application of a vinblastine-selected CACO-2 cell line for evaluation of p-glycoprotein.

Authors:  Dennis A Laska; Jack O Houchins; Susan E Pratt; Jeffery Horn; Xialong Xia; Brenda R Hanssen; Daniel C Williams; Anne H Dantzig; Terry Lindstrom
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Jul-Aug       Impact factor: 2.416

7.  Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers.

Authors:  H M Faessel; A H Burstein; M D Troutman; S A Willavize; K D Rohrbacher; D J Clark
Journal:  Eur J Clin Pharmacol       Date:  2008-07-26       Impact factor: 2.953

8.  Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction.

Authors:  Jens Rengelshausen; Christoph Göggelmann; Jürgen Burhenne; Klaus-Dieter Riedel; Jochen Ludwig; Johanna Weiss; Gerd Mikus; Ingeborg Walter-Sack; Walter E Haefeli
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

9.  Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.

Authors:  P Annaert; J Van Gelder; L Naesens; E De Clercq; G Van den Mooter; R Kinget; P Augustijns
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

10.  Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.

Authors:  V D Makhey; A Guo; D A Norris; P Hu; J Yan; P J Sinko
Journal:  Pharm Res       Date:  1998-08       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.